Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Ronald Josey

Assessing Upwork: Insights From 8 Financial Analysts

8 analysts have expressed a variety of opinions on Upwork (NASDAQ:UPWK) over the past quarter, offering a diverse set of opinions from bullish to bearish.

Citi's Key Takeaways On Amazon's Recent Management Reshuffle

Citi's Key Takeaways On Amazon's Recent Management Reshuffle

Citi analyst Ronald Josey revisited Amazon.com Inc's (NASDAQ:AMZN), naming veteran executive Doug Herrington as CEO of Worldwide Amazon Stores (renamed from Worldwide Consumer) and promoting John Felton as its new head of Operations. Given this announcement comes ~2 weeks post Dave Clark's resignation, Josey expected minimal disruption to store operations. While Josey recognized the challenges…

Here's Why Citi Remains Bullish On Amazon Despite Knocking It Off Focus List

Here's Why Citi Remains Bullish On Amazon Despite Knocking It Off Focus List

Citi analyst Ronald Josey considers Amazon.com Inc (NASDAQ: AMZN) vulnerable to softening consumer spending trends.

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Mark This Date, Then Wait to Buy Airbnb Stock

Airbnb (ABNB) stock is stuck in a frustrating, choppy range and could have its breakthrough moment soon - and a data release could be make-or-break.

Here's Why Citi Added Amazon To Focus List

Citi analyst Ronald Josey assumed coverage of Amazon.com Inc (NASDAQ:AMZN) with a Buy rating and price target of $4,100, down from $4,115 (29.7% upside). Josey also added the shares to the firm's Focus List, given its lead eCommerce, Online Advertising, and Cloud and operational efficiencies at its new Fulfillment Centers, physical retail location closures, and…

Read Why JMP Securities Lowered Price Target On Rover Group

JMP Securities analyst Ronald Josey lowered the price target on Rover Group Inc (NASDAQ:ROVR) to $11 (131% upside) from $15 and kept an Outperform rating on the shares post Q4 results. The analyst stated that omicron has increased cancellation rates in Q4 and impacted demand in Q1, limiting revenue visibility for 2022. In the longer…

1

People

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

Amazon.com Inc.

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play